[Current treatment with clofibrate or clofibric acid (Regadrin)].
D002769:Cholelithiasis / Q000139:chemically induced; D002784:Cholesterol / Q000378:metabolism; D002994:Clofibrate / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D002995:Clofibric Acid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000188:drug therapy; D014280:Triglycerides / Q000378:metabolism
D014280:Triglycerides; D002995:Clofibric Acid; D002784:Cholesterol; D002994:Clofibrate
Zum aktuellen Stand der Therapie mit Clofibrat bzw. Clofibrinsäure (Regadrin).